"Back to a more relevant point - the question around office costs is a reasonable one in light of the recent revelations. Shareholders might want to be reassured that CGB is not funding / subsidising or providing any support (financial or otherwise) to Mars Mines Limited."
And this is where things can get real messy.
Only got to look at the company's history to arrive at a reasonable conclusion.
- Forums
- ASX - By Stock
- CGB
- Court Update November 28th 2022 Medcan v CGB
Court Update November 28th 2022 Medcan v CGB, page-37
-
- There are more pages in this discussion • 200 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online